|
|
|
|
NAMs are transforming toxicology with human-relevant, non-animal approaches. Learn what defines a NAM, how these methods work together, and why adoption is rapidly accelerating.
|
|
|
|
|
Policy and scientific validation have aligned to shift drug development beyond animal models. New regulations and technologies are making human‑relevant methods the standard for preclinical research.
|
|
|
|
|
Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.
|
|
|
|
|
As deep space missions return, new research is uncovering how human biology adapts beyond Earth. Advanced tissue models offer fresh insight into bone marrow response, opening new possibilities.
|
|
|
|
|
Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.
|
|
|
|
|
Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.
|
|
|
|
|
Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.
|
|
|
|
|
|
|
As regulatory momentum continues growing to reduce and replace animal models with more human-relevant approaches, Emulate’s Organ-on-a-Chip technology can help researchers generate translational insights earlier in the R&D process and expedite their IND submissions.
From toxicology and safety testing to biologics development, neuroscience, cancer medicine, and space biology, Emulate’s Organ-Chip platforms support more predictive and human-centric approaches to drug development and disease modeling.
Download Brochure.
|
|
|
